Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION [SIN15302P]

Active ingredients: CHROMIC CHLORIDE HEXAHYDRATE | COPPER CHLORIDE DIHYDRATE | FERRIC CHLORIDE HEXAHYDRATE | MANGANESE CHLORIDE TETRAHYDRATE | POTASSIUM IODIDE | SODIUM FLUORIDE | SODIUM MOLYBDATE DIHYDRATE | SODIUM SELENITE ANHYDROUS | ZINC CHLORIDE

View product's general information
Last updated 28 July 2026

Product Info

ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION

[SIN15302P]

Product information

Active Ingredient and Strength

CHROMIC CHLORIDE HEXAHYDRATE - 5.33 MCG/ML
COPPER CHLORIDE DIHYDRATE - 102.3 MCG/ML
FERRIC CHLORIDE HEXAHYDRATE - 540 MCG/ML
MANGANESE CHLORIDE TETRAHYDRATE - 19.79 MCG/ML
POTASSIUM IODIDE - 16.6 MCG/ML
SODIUM FLUORIDE - 210 MCG/ML
SODIUM MOLYBDATE DIHYDRATE - 4.85 MCG/ML
SODIUM SELENITE ANHYDROUS - 17.29 MCG/ML
ZINC CHLORIDE - 1,050 MCG/ML

Dosage Form

INFUSION, SOLUTION CONCENTRATE

Manufacturer and Country

HP HALDEN PHARMA AS - NORWAY

Registration Number

SIN15302P

Licence Holder

FRESENIUS KABI (SINGAPORE) PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

B05XA31

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

4.1 Therapeutic indications

To meet basal to moderately increased requirements of trace elements in intravenous nutrition.

Dosing

4.2 Posology and method of administration

Posology

Adults: The recommended daily dose of Addaven in adult patients with basal to moderately increased requirements is 10 ml (one ampoule).

In patients with renal or hepatic impairments, or mild cholestasis the dose should be adapted.

Children ≥ 15 kg: 0.1 ml Addaven is given per kg body weight and day.

Method of administration

Addaven must not be given undiluted. Addaven shall be given as an intravenous infusion, diluted in a parenteral nutrition solution/emulsion.
For instructions on dilution of the medicinal product before administration, see section 6.6 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.

Contraindications

4.3 Contraindications

  • Hypersensitivity to the active substances or to any of the excipients listed in section 6.1 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.

  • Conditions with total biliary obstruction.

  • Wilson’s disease, hemochromatosis.

  • Children less than 15 kg body weight.